1-5 of 5
Doo Hyun Chung
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Transcriptomic Heterogeneity of EGFR-Mutant Non–Small Cell Lung Cancer Evolution Toward Small-Cell Lung Cancer

Songji Oh, Jaemoon Koh, Tae Min Kim, Soyeon Kim, Jeonghwan Youk, Miso Kim, Bhumsuk Keam, Yoon Kyung Jeon, Ja-Lok Ku, Dong-Wan Kim, Doo Hyun Chung, Dae Seog Heo
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (20): 4729–4742.
https://doi.org/10.1158/1078-0432.CCR-24-0160
Published: 15 October 2024
View articletitled, Transcriptomic Heterogeneity of EGFR-Mutant Non–Small Cell Lung Cancer Evolution Toward Small-Cell Lung Cancer
Open the PDF for Transcriptomic Heterogeneity of EGFR-Mutant Non–Small Cell Lung Cancer Evolution Toward Small-Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

IL23-Producing Human Lung Cancer Cells Promote Tumor Growth via Conversion of Innate Lymphoid Cell 1 (ILC1) into ILC3

Jaemoon Koh, Hye Young Kim, Youngha Lee, In Kyu Park, Chang Hyun Kang, Young Tae Kim, Ji-Eun Kim, Murim Choi, Won-Woo Lee, Yoon Kyung Jeon, Doo Hyun Chung
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (13): 4026–4037.
https://doi.org/10.1158/1078-0432.CCR-18-3458
Published: 01 July 2019
View articletitled, IL23-Producing Human Lung Cancer Cells Promote Tumor Growth via Conversion of Innate Lymphoid Cell 1 (ILC1) into ILC3
Open the PDF for IL23-Producing Human Lung Cancer Cells Promote Tumor Growth via Conversion of Innate Lymphoid Cell 1 (ILC1) into ILC3 in another window
Includes: Supplementary data
Journal Articles

Pan-Cancer Immunogenomic Perspective on the Tumor Microenvironment Based on PD-L1 and CD8 T-Cell Infiltration

Chan-Young Ock, Bhumsuk Keam, Sehui Kim, Ju-Seog Lee, Miso Kim, Tae Min Kim, Yoon Kyung Jeon, Dong-Wan Kim, Doo Hyun Chung, Dae Seog Heo
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (9): 2261–2270.
https://doi.org/10.1158/1078-0432.CCR-15-2834
Published: 01 May 2016
View articletitled, Pan-Cancer Immunogenomic Perspective on the Tumor Microenvironment Based on PD-L1 and CD8 T-Cell Infiltration
Open the PDF for Pan-Cancer Immunogenomic Perspective on the Tumor Microenvironment Based on PD-L1 and CD8 T-Cell Infiltration in another window
Includes: Supplementary data
Journal Articles

Abstract A22: Clinical implication of microscopic anthracotic pigment in mediastinal staging of non-small cell lung cancer by endobronchial ultrasound-guided transbronchial needle aspiration

Young Whan Kim, Young Sik Park, Jinwoo Lee, Sang-Min Lee, Jae-Joon Yim, Sung Koo Han, Jin Chul Pang, Doo Hyun Chung, Seok-Chul Yang
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (3_Supplement): A22.
https://doi.org/10.1158/1078-0432.12AACRIASLC-A22
Published: 01 February 2012
View articletitled, Abstract A22: Clinical implication of microscopic anthracotic pigment in mediastinal staging of non-small cell lung cancer by endobronchial ultrasound-guided transbronchial needle aspiration
Open the PDF for Abstract A22: Clinical implication of microscopic anthracotic pigment in mediastinal staging of non-small cell lung cancer by endobronchial ultrasound-guided transbronchial needle aspiration in another window
Journal Articles

Optimization of Patient Selection for Gefitinib in Non–Small Cell Lung Cancer by Combined Analysis of Epidermal Growth Factor Receptor Mutation, K-ras Mutation, and Akt Phosphorylation

Sae-Won Han, Tae-You Kim, Yoon Kyung Jeon, Pil Gyu Hwang, Seock-Ah Im, Kyung-Hun Lee, Jee Hyun Kim, Dong-Wan Kim, Dae Seog Heo, Noe Kyeong Kim, Doo Hyun Chung, Yung-Jue Bang
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (8): 2538–2544.
https://doi.org/10.1158/1078-0432.CCR-05-2845
Published: 25 April 2006
View articletitled, Optimization of Patient Selection for Gefitinib in Non–Small Cell Lung Cancer by Combined Analysis of Epidermal Growth Factor Receptor Mutation, K-ras Mutation, and Akt Phosphorylation
Open the PDF for Optimization of Patient Selection for Gefitinib in Non–Small Cell Lung Cancer by Combined Analysis of Epidermal Growth Factor Receptor Mutation, K-ras Mutation, and Akt Phosphorylation in another window